XSWX:PPGN (Switzerland)  
PolyPeptide Group AG logo

PolyPeptide Group AG

CHF 42.00 (-0.47%) Aug 16
P/E:
26.72
P/B:
3.17
Market Cap:
CHF 1.39B ($ 1.46B)
Enterprise V:
CHF 1.28B ($ 1.34B)
Volume:
24.09K
Avg Vol (2M):
74.41K
Volume:
24.09K
Market Cap CHF:
1.39B
Market Cap $:
1.46B
PE Ratio:
26.72
Avg Vol (2-Month):
74.41K
Enterprise Value CHF:
1.28B
Enterprise Value $:
1.34B
PB Ratio:
3.17
GF Score:
Year:
EMBED
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website Sources Stock Report
Dataset
Financial Download Tutorials

Business Description

Description
PolyPeptide Group AG is a contract development and manufacturing organization. It focuses on proprietary and generic GMP-grade peptides used by pharmaceutical and biotech companies in approved pharmaceutical products, drugs in clinical development as well as in generic products.
Name Current Vs Industry Vs History
Cash-To-Debt 7.57
Equity-to-Asset 0.71
Debt-to-Equity 0.04
Debt-to-EBITDA 0.21
Interest Coverage 22.76
Piotroski F-Score 7/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 6.35
Distress
Grey
Safe
Beneish M-Score -2.42
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 38.59
9-Day RSI 34.3
14-Day RSI 33.52
6-1 Month Momentum % -42.89
12-1 Month Momentum % -52.78

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.19
Quick Ratio 2.1
Cash Ratio 1.31
Days Inventory 209.1
Days Sales Outstanding 71.01
Days Payable 46.71

Dividend & Buy Back

Name Current Vs Industry Vs History
Dividend Yield % 0.71
Forward Dividend Yield % 0.71
5-Year Yield-on-Cost % 0.71
3-Year Average Share Buyback Ratio -3.3

Financials

XSWX:PPGN's 30-Y Financials

Guru Trades

See Details
To
EMBED
SAVE

Insider Trades

See Details
To
EMBED
SAVE

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To
EMBED
SAVE
Dividend
To
EMBED
SAVE

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

EMBED

Valuation Box

Year:
EMBED

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil CHF) 300.772
EPS (TTM) (CHF) 1.572
Beta 0
Volatility % 66.66
14-Day RSI 33.52
14-Day ATR (CHF) 2.511117
20-Day SMA (CHF) 44.468
12-1 Month Momentum % -52.78
52-Week Range (CHF) 38.02 - 147.4
Shares Outstanding (Mil) 33.1

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 7
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

PolyPeptide Group AG Filings

Document Form Filing Date
No Filing Data